Posts
News
NEWS
AFNET Image film
Explore our image film and see who’s behind AFNET.
Four researchers receive DGK AFNET Young Investigator Award for atrial fibrillation
At the annual meeting of the German Society of Cardiology (DGK), four scientists will be…
20 Years of AFNET-Booklet
We are pleased to present you our bookelt on the occasion of our 20th anniversary.
You…
ESC Congress 2023
ANET associated events:
25 August 2023, 8:30, “Stockholm”, Stroke and bleeding risk in atrial fibrillation: walking the tight rope…
Is early rhythm control in atrial fibrillation care cost-effective? An analysis based on the EAST – AFNET 4 trial
Is early rhythm control in atrial fibrillation care cost-effective? An analysis based on the EAST…
AXADIA-AFNET8 and EAST-AFNET4 @ AHA Congress 2022
The results of the AXADIA-AFNET8 trial and another EAST-AFNET4 subanalysis will be presented at this year’s…
EAST-AFNET 4 @ World Stroke Congress– WSC 2022
Session 0880 – Plenary 01: Opening, Presentation of Award and Late Breaking Trials (ID 294)…
Better therapy for patients with heart failure and atrial fibrillation (CABA-HFPEF-DZHK27 trial)
The study “CABA-HFPEF-DZHK27” (CAtheter-Based Ablation of atrial fibrillation vs. conventional treatment in patients with Heart Failure with Preserved Ejection Fraction) is…
8th AFNET/EHRA Consensus Conference 2021 Paper published
The 8th AFNET/EHRA Consensus Conference Paper 2021 “Early diagnosis and better rhythm management to improve…
PRESS RELEASES
Patients with rare and short atrial arrhythmias do not benefit from anticoagulation
The clinical trial NOAH – AFNET 6 conducted by the German Atrial Fibrillation Network (AFNET),…
Do patients with rare and short atrial arrhythmias need anticoagulation to prevent strokes?
A review article written by the NOAH – AFNET 6 investigators led by Tobias Tönnis…
Early rhythm control is effective and safe in AF patients irrespective of a genetic predisposition
A sub-study analysis of the EAST – AFNET 4 trial revealed how genetic risk for…
Early rhythm control reduces cardiovascular outcomes in patients with atrial fibrillation and prior stroke
Patients with atrial fibrillation (AF) and a history of stroke are at high risk of…
Wearable-based screening identified atrial fibrillation in five percent of older adults
Consumer electronics provide a novel route to screen for atrial arrhythmias. The Smart in OAC…
AXADIA – AFNET 8 trial supports oral anticoagulation with Apixaban in AF patients on hemodialysis
In the AXADIA – AFNET 8 trial, oral anticoagulation with the non-vitamin K antagonist oral…
Early rhythm control for atrial fibrillation reduces cardiovascular outcomes in patients with prior stroke
Patients with atrial fibrillation (AF) and a history of stroke are at high risk of…
AFNET terminates NOAH – AFNET 6 trial ahead of time
The NOAH – AFNET 6 trial which is conducted to evaluate the potential benefit of…
Attaining sinus rhythm mediates improved outcomes with early rhythm control therapy of atrial fibrillation
A mediator analysis of the EAST – AFNET 4 trial dataset revealed the key factor…